| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7660c356e340012e7f21d12e56a91da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-54 |
| filingDate |
2018-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3fc9929c1b6b8e129f90fb94cc5bef2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f90481dbd4a9c584dc49d8e84d5569a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50180f1e2e3f71c6f15383b7ff5a4189 |
| publicationDate |
2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10675266-B2 |
| titleOfInvention |
Compounds and methods for treating autism spectrum disorders |
| abstract |
The present invention relates to a compound of the following formula (I): n n n n n n n n n n or a pharmaceutically acceptable salt thereof, n for use in the prevention or treatment of autism spectrum disorders (ASD). |
| priorityDate |
2008-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |